Guardian Capital Advisors LP Bristol Myers Squibb CO Transaction History

Guardian Capital Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $63,710 - $70,740	-1,000 Reduced 14.71%	5,800 $370,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $16,427 - $18,632	-250 Reduced 3.55%	6,800 $471,000
Q2 2021 Aug 17, 2021	SELL	$61.91 - $67.42 $130,011 - $141,582	-2,100 Reduced 22.95%	7,050 $472,000
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $127,581 - $143,491	2,150 Added 30.71%	9,150 $584,000
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $16,446 - $19,227	300 Added 4.48%	7,000 $297,000
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $59,940 - $65,349	-1,000 Reduced 12.99%	6,700 $417,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,700	7,700 $421,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital Advisors LP with notifications on news.